SCHEMBL21991721

SCHEMBL21991721

C=C(Nc1ccc(P)c(C)c1)c1ccc(C)c(C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 6/20 0.44
▸ NPC1 O15118 5/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ POLB P06746 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ FKBP5 Q13451 1/20 0.39
▸ GAA P10253 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HDAC3 O15379 1/20 0.37
▸ HDAC4 P56524 1/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC7 Q8WUI4 1/20 0.37
▸ HDAC2 Q92769 1/20 0.37
▸ HDAC10 Q969S8 1/20 0.37
▸ HDAC11 Q96DB2 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.37
▸ HDAC9 Q9UKV0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20779328 0.82 KMT2A (0.42) RAB9ANPC1KMT2APOLBALDH1A1
SCHEMBL21416769 0.76 NPSR1 (0.43) RAB9ANPC1KMT2APOLBALDH1A1
SCHEMBL24137699 0.75 NPC1 (0.42) RAB9ANPC1KMT2APOLBALDH1A1
SCHEMBL21417007 0.73 NPC1 (0.42) RAB9ANPC1KMT2APOLBALDH1A1
SCHEMBL18844775 0.73 NPC1 (0.46) RAB9ANPC1KMT2APOLBALDH1A1
SCHEMBL13885945 0.71 TOP1 (0.42) KMT2AALDH1A1MEN1GAACYP1A2
SCHEMBL15627037 0.70 POLB (0.57) RAB9ANPC1KMT2APOLBALDH1A1
SCHEMBL23476007 0.70 PRSS1 (0.47) RAB9ANPC1KMT2APOLBALDH1A1
SCHEMBL823156 0.69 RAB9A (0.75) RAB9ANPC1KMT2APOLBMEN1
SCHEMBL22966294 0.68 MEN1 (0.36) RAB9ANPC1KMT2APOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3227262-B1 SULFIDE ALKYL AND PYRIDYL REVERSE SULFONAMIDE COMPOUNDS FOR HBV TREATMENT NOVIRA THERAPEUTICS INC (US) 2020-05-13 — — EP disclosed
Send feedback